Literature DB >> 23458112

Schema change without schema therapy: the role of early maladaptive schemata for a successful treatment of major depression.

Ingo Wegener1, Susanne Alfter, Franziska Geiser, Reinhard Liedtke, Rupert Conrad.   

Abstract

Early maladaptive schemata (EMS) have repeatedly been shown to be associated with several psychopathological conditions, including depression. Schema therapy proposes interventions that aim at altering EMS. In the present study, we examined the effect of an integrative psychodynamic inpatient therapy without explicit focus on EMS in a sample with major depression. Forty-seven (38 female, 9 male) patients filled out the Symptom Checklist (SCL-90-R) and the Young Schema Questionnaire (YSQ) at the beginning and end of the treatment. Results revealed that EMS were significantly reduced in three out of five schema domains. Strong endorsement of EMS at the beginning of treatment tended to predict symptom reduction. More importantly, the reduction of symptom distress during treatment was strongly associated with a reduction in EMS of the schema domain Impaired Autonomy/Performance. We discuss that changes in EMS are highly relevant for changes in symptom distress but that EMS can not only be changed by schema therapy but also by other approaches, like psychodynamic therapy.

Entities:  

Mesh:

Year:  2013        PMID: 23458112     DOI: 10.1521/psyc.2013.76.1.1

Source DB:  PubMed          Journal:  Psychiatry        ISSN: 0033-2747            Impact factor:   2.458


  2 in total

1.  Early maladaptive schemas and COVID-19 anxiety: The mediational role of mistrustfulness and vulnerability to harm and illness.

Authors:  Bruno Faustino; António Branco Vasco; João Delgado; António Farinha-Fernandes; José Carlos Guerreiro
Journal:  Clin Psychol Psychother       Date:  2022-01-17

2.  Multidimensional Analysis of Major Depression: Association Between BDNF Methylation, Psychosocial and Cognitive Domains.

Authors:  María Marcela Velásquez; Yvonne Gómez-Maquet; Eugenio Ferro; Wilmer Cárdenas; Silvia González-Nieves; María Claudia Lattig
Journal:  Front Psychiatry       Date:  2021-12-14       Impact factor: 4.157

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.